key: cord-0773445-zh3h4597
authors: Mergen, Victor; Kobe, Adrian; Blüthgen, Christian; Euler, André; Flohr, Thomas; Frauenfelder, Thomas; Alkadhi, Hatem; Eberhard, Matthias
title: Deep learning for automatic quantification of lung abnormalities in COVID-19 patients: first experience and correlation with clinical parameters
date: 2020-10-06
journal: Eur J Radiol Open
DOI: 10.1016/j.ejro.2020.100272
sha: 43382fec9387ce9b1a3f0abadb0f479028c89552
doc_id: 773445
cord_uid: zh3h4597

RATIONALE AND OBJECTIVES: To demonstrate the first experience of a deep learning-based algorithm for automatic quantification of lung parenchymal abnormalities in chest CT of COVID-19 patients and to correlate quantitative results with clinical and laboratory parameters. MATERIALS AND METHODS: We retrospectively included 60 consecutive patients (mean age, 61 ± 12 years; 18 females) with proven COVID-19 infection undergoing chest CT between March and May 2020. Clinical and laboratory data (within 24 hours before/after chest CT) were recorded. Prototype software using a deep learning algorithm was applied for automatic segmentation and quantification of lung opacities. Percentage of opacity (PO, ground-glass and consolidations) and percentage of high opacity (PHO, consolidations), were defined as 100 times the volume of segmented abnormalities divided by the volume of the lung mask. RESULTS: Automatic CT analysis of the lung was feasible in all patients (n = 60). The median time to accomplish automatic evaluation was 120 s (IQR: 118–128 s). In four cases (7%), manual corrections were necessary. Patients with need for mechanical ventilation had a significantly higher PO (median 44%, IQR: 23-58% versus 13%, IQR: 10-24%; p = 0.001) and PHO (median: 11%, IQR: 6-21% versus 3%, IQR: 2-7%, p = 0.002) compared to those without. The PO and PHO moderately correlated with c-reactive protein (r = 0.49-0.60, both p < 0.001) and leucocyte count (r = 0.30-0.40, both p = 0.05). PO had a negative correlation with SO(2) (r=-0.50, p = 0.001). CONCLUSION: Preliminary experience indicates the feasibility of a rapid, automatic quantification tool of lung parenchymal abnormalities in COVID-19 patients using deep learning, with results correlating with laboratory and clinical parameters.

In 2020 a novel, highly infectious coronavirus, SARS-CoV-2, rapidly developed to a worldwide pandemic. The clinical appearance of the infection ranges from mild symptoms to fulminant acute respiratory distress syndrome [1] [2] [3] . Due to the rapidly growing flood of patients in need for medical care, health care systems were quickly on the verge of collapse.

Recent experience showed that it was difficult to respond efficiently to this extreme demand even in developed Western countries [4] .

Recently, efforts have been made to implement deep learning-based concepts into medicine to optimize and streamline workflows [5] [6] [7] . During the processing of a deep learning-based system a convolutional neural network is trained on a defined, annotated dataset [8] . Subsequently, the algorithm acquires the ability to perform the questioned analysis by itself. In radiology, automated recognition and segmentation of pathology may speed-up diagnosis, quantifies disease, and could help in decision-making processes [9] [10] [11] .

So far, a few studies assessed the value of machine learning-based algorithms in chest computed tomography (CT) of patients suffering from corona virus infectious disease 2019 [8, 11, 12] . Huang et al. [8] quantitatively evaluated disease burden changes over time in patients with different severity of COVID-19 infection using a deep learning-based software, showing differences in the quantity of lung opacification among groups with different disease severity. Li et al. [11] reported the ability of a neural network to accurately diagnose COVID-19 on chest CT distinguishing it from other infectious diseases. Shi et al. [12] developed a deep-learning based model containing five clinical and radiological features to predict the severity of COVID-19 infection, yielding a significantly higher accuracy than a quantitative assessment of CT images alone [12] . From this preliminary experience it can be assumed that full exploitation of machine learning-based computer aided systems might be J o u r n a l P r e -p r o o f 6 beneficial in the setting of overwhelming and rapidly increasing patient loads such as that currently occurring during the COVID-19 pandemic.

The purpose of our study was to demonstrate the first experience of a newly developed, deep learning-based algorithm for the automatic quantification of lung parenchymal abnormalities in chest CT of COVID-19 positive patients and to correlate those results with clinical and laboratory parameters.

J o u r n a l P r e -p r o o f

This retrospective study was approved by the local Ethics Committee and conducted according to the principles of the Declaration of Helsinki. Consent was obtained from all study subjects. We included all 60 consecutive patients (mean age, 61 ± 12 years; 18 females, 42 males) with proven COVID-19 infection who underwent chest CT between March and May 2020 in our hospital. SARS-CoV-2 was confirmed by reverse transcription polymerase chain reaction (RT-PCR) from nasal-pharyngeal swabs in all patients (n=60). Detailed patient demographics are shown in table 1.

Clinical data (cough, dyspnea) were recorded at admission, the highest values of laboratory data (c-reactive protein, CRP, leucocytes, interleukin 6, IL-6), temperature, and peripheral oxygen saturation (SO2) within 24 hours before/after chest CT were noted. Need for oxygen supply and mechanical ventilation during hospitalization was noted.

Patients underwent either non-enhanced (n=31, 52%) or contrast-enhanced (n=29, 48%) chest CT on a 128-slice single-source CT scanner (SOMATOM Definition Edge Plus;

Siemens Healthineers, Forchheim, Germany). Scan parameters were as follows: reference tube voltage 100 kV with automated tube voltage selection (CARE kV); 100 mAs reference tube current-time product with automated attenuation-based tube current modulation (CARE Dose4D); and gantry rotation time 0.28 s. The following reconstruction parameters were applied: sharp convolution kernel; slice increment, 1.0 mm; and slice thickness, 1.5 mm. According to the results of quantification, the algorithm adjudicates a 5-point infection score as described by Bernheim et al. [13] with 0 indicating no involvement; 1, less than 25% J o u r n a l P r e -p r o o f involvement (PO<25); 2, 25-49% involvement (25≤PO≤49); 3, 50-74% involvement (50≤PO≤74); and 4, 75-100% involvement (75≤PO≤100). Further details of the algorithms used herein can be found elsewhere [14] .

All CT image analyses were carried out on a standard dedicated workstation (Intel Xeon W-2125 CPU 4.00 GHz; 32.0 GB RAM) at our institution. All automatic analyses were reviewed by a board-certified radiologist and corrected if necessary. The time from starting the automatic CT analysis to the availability of results were recorded. Feasibility of automatic CT segmentation was analyzed for each case, and the necessity of manual corrections was assessed.

Normality of continuous data was assessed using the Shapiro-Wilk test. Non-normally distributed continuous data were indicated as median and inter-quartile range (IQR). Normally distributed continuous data were shown as mean ± standard deviation. Sign test, Wilcoxon signed rank test, and the Friedman test were applied to analyze paired data as appropriate. Posthoc Bonferroni testing was applied for the Friedman test. For correlations, Pearson's correlation or Spearman's rank correlation were applied were appropriate. A two-sided p-value below 0.05 was considered to indicate statistical significance. All analyses were performed with commercially available software (SPSS for Windows 25.0, Chicago, IL, USA). 

Automatic deep learning-based CT analysis of the lung was feasible in all patients (n=60). The median time to finish the automatic evaluation was 120 sec (IQR: 118-128 sec).

In four cases (7%) manual corrections were necessary. Two of these cases showed atelectasis which were only partially automatically segmented, and in two cases ground-glass opacities were partially missed by the algorithm. The median infection score was 2 (IQR: 1-2), with no significant differences between the right (median: 2, IQR: 1-2) and left lung (median: 2, IQR: 1-2, p=0.327, Table 2 ).

Furthermore, there were no differences in the proportion of PO and PHO between the left and right lung (both, p>0.05).

The left lower lobe (LLL; median: 46%, IQR: 11-70%) and the right lower lobe (RLL; median: 44%, IQR: 21-78%) showed the highest PO with significant differences compared to the middle lobe (ML) and the left upper lobe (LUL; p<0.001 for all, see Table 2 ) and between the RLL and the right upper lobe (p=0.047).

J o u r n a l P r e -p r o o f 11 The LLL (median: 9%, IQR: 2-24%) and the RLL (median: 12%, IQR: 3-30%) showed the highest PHO with significant differences compared to the ML and the LUL (p<0.001 for all; see Table 2 ).

Patients with need for mechanical ventilation had a significantly higher PO (median [2, 16, 17] . Lately, a few reports described initial experiences with automated deep-learning approaches [8, 11, 12] or semi-automated non-deep learning approaches [18, 19] to correctly diagnose COVID-19 or to derive quantitative chest CT results. Huang et al. [8] used a commercially available deep learning algorithm trained on an annotated dataset of COVID-19 patients, providing quantitative results for PO in baseline CT, however, the algorithm did not differentiate between GGO and consolidations. Authors did not manually adjust the automatic segmentation, and 9% of cases were excluded due to poor segmentation. In 56 out of 212 scans the segmentation indicated a perfect fit with lung opacities, while in the other cases minor imperfections were noted [8] . [8, 12] . Li et al. [11] reported an average processing time of 5 seconds for their deep learning algorithm, however, this algorithm was used for disease detection and did not provide quantitative results. correction was necessary in 61% of cases. Authors observed that software-determined well aerated lung parenchyma of less than 71% was associated with ICU admission or death.

In our study, a prototype deep-learning based software was applied. Comparing our results to that from Colombi et al. [18] , the deep learning algorithm provided a faster (120 s vs. 270 s) and more accurate segmentation with post-hoc corrections only necessary in 7% of cases (vs. 61%). Lanza et al [19] reported a median time for segmentation of 11 minutes. The automatic chest CT analysis in our study was carried out on a standard PACS workstation of our institution. Using faster hardware equipment may speed-up automatic lung evaluation to a significant degree [14] .

Similar to previous studies, our study showed that the extent of lung opacities and consolidations increase with laboratory and clinical severity of disease [1, 8, 12, 20] , adding objective, quantitative aspects to the analysis of chest CT. Especially in follow-up chest CT, reliable and rapid automatic quantification of abnormalities may support radiologists in determining disease progression or regression. However, we must admit that the number of cases in our study was overall too small, and only a minority of these patients obtained followup CT. Thus, evaluating the usefulness of this tool for follow-up CT examinations was not possible.

The following limitations of our study merit consideration. First, the study suffers from inherent shortcomings of a retrospective, single-center approach. Second, CT was acquired during various clinical stages of disease, potentially including bias into the analysis of the correlation between quantitative CT parameters and clinical and laboratory findings. Third, we did not assess whether the deep learning algorithm is able to differentiate patterns of different pulmonary infection. Fourth, we did no compare the accuracy of segmentation of lung parenchymal abnormalities of this algorithm with other automatic tools. Finally, our study lacks mid-and long-term follow-up outcome data to determine the value of such algorithms for patient care.

In conclusion, our preliminary experience indicates the feasibility of a rapid, automatic quantification tool for lung parenchymal abnormalities in COVID-19 patients using deep learning. The algorithm has the potential to speed up chest CT evaluation of COVID-19 positive patients providing quantitative parameters. Future studies should assess whether such parameters may add prognostic value beyond laboratory and clinical results alone. Abbreviations: IQR, inter-quartile range; SD, standard deviation; °C, degrees Celsius; SO2, peripheral oxygen saturation; CRP, C-reactive protein; IL-6, Interleukin 6 

Clinical features of patients infected with 2019 novel coronavirus in

Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes

Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features

Corona Virus International Public Health Emergencies: Implications for Radiology Management

Machine learning and deep neural networks: applications in patient and scan preparation, contrast medium, and radiation dose optimization

Current applications and future impact of machine learning in radiology

Artificial Intelligence in Medicine: Where Are We Now?

Serial quantitative chest ct assessment of covid-19: Deep-learning approach

Automatic pulmonary nodule detection applying deep learning or machine learning algorithms to the LIDC-IDRI database: A systematic review

Deep Learning Applications in Chest Radiography and Computed Tomography

Deep Learning-Based Quantitative Computed Tomography model in Predicting the Severity of COVID-19: A Retrospective Study in 196 Patients

Relationship to Duration of Infection

Quantification of Tomographic Patterns associated with COVID-19 from Chest CT

Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT

COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review

Review of chest CT manifestations of COVID-19 infection

Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia

Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, The Lancet Infectious Diseases

Abbreviations: IQR, inter-quartile range; LDH, lactate dehydrogenase; SD

SaO2, arterial oxygen saturation